The DOI matches its Crossref record; 231 of the 231 references it cites were found in a registry or an index.
Drugging the efferocytosis process: concepts and opportunities
Open accessAbstract
The daily removal of billions of apoptotic cells in the human body via the process of efferocytosis is essential for homeostasis. To allow for this continuous efferocytosis, rapid phenotypic changes occur in the phagocytes enabling them to engulf and digest the apoptotic cargo. In addition, efferocytosis is actively anti-inflammatory and promotes resolution. Owing to its ubiquitous nature and the sheer volume of cell turnover, efferocytosis is a point of vulnerability. Aberrations in efferocytosis are associated with numerous inflammatory pathologies, including atherosclerosis, cancer and infections. The recent exciting discoveries defining the molecular machinery involved in efferocytosis have opened many avenues for therapeutic intervention, with several agents now in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“efferocytosis in other settings can promote fibrosis as part of the tissue resolution process, for example, by secreting TGF-β1 (12, 13).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While some progress has been made with respect to the Fractalkine receptor (CX3C motif chemokine receptor 1), Axl, MerTK, CD47 and Tim4/3, no approaches have thus far been clinically approved (64).”
From Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells (2026) · cites this paper as [64]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The accumulation of dead cells in disease settings indicates impaired clearance of dead cells by macrophages (“efferocytosis”) (12, 13).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Efferocytosis not only prevents dead cell accumulation but also reprograms macrophages to execute tissue resolution functions, and impaired efferocytosis contributes to many human chronic inflammatory diseases (12, 13).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [13]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“It is seen as a major hurdle to using antigen presenting cells in cell-based therapies (61–64).”
From Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells (2026) · cites this paper as [64]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tan, X., Zhang, Z., Yao, H., & Shen, L. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.012 · Cited by 76
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Cappello, V., Marchetti, L., Parlanti, P., Landi, S., Tonazzini, I., Cecchini, M., Piazza, V., & Gemmi, M. (2016) · Scientific Reports · doi:10.1038/s41598-016-0001-8 · Cited by 13,097
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,414
Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J., Bratton, D. L., & Henson, P. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.2207 · Cited by 3,321
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Research works printed but not linked: 4
- Urbani, L. et al. in Transplantation Proceedings 1175–1178 (Elsevier, 2004).
- Dalli, J., Colas, R., Shinohara, M. & Serhan, C. N. Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving. Medicines 193, 4235–4244 (2014).
- Noelia, A. et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31, 245–258 (2009). This important study highlights the role of nuclear receptors in anti-inflammatory effects of efferocytosis and plausible therapeutic advantages of targeting the pathway. · DOI
- Bohan, D. et al. Targeting the receptor AXL by bemcentinib prevents SARS-CoV-2 infection. Top. Antivir. Med. 29, 137–138 (2021).
Cited by
Sorted by citations
Items 401–475 of 475
Fang, Y., Yin, W., Han, N., Li, Z., He, A., Zhang, Y., Gu, H., Lang, M., & Ruan, M. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.176973
Sanders, B., Korthauer, M., Parihar, K. S., & Ifergan, I. (2026) · Experimental Neurology · doi:10.64898/2026.04.27.720934
Assessing the activity of caspase-activated pannexin-1 channels by flow cytometry
Hector, M. B. P. F., Poon, I. K. H., & Santavanond, J. P. (2026) · Methods in cell biology · doi:10.1016/bs.mcb.2026.04.003
Ye, S.-Y., Qu, Y., Zhang, J.-H., Wang, X.-H., Wang, J., Xue, Y., & Liu, J.-D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1835168
Mathure, S. A., Maghinang, K., & Smith-Bolton, R. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.04.722804
Liao, Q., Zhang, S., Xie, Y., Tan, Q. C., Li, T., Yang, S., Xu, C., Tuo, Z., Yao, R., Zhang, L., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04534-8
Wang, A., Ye, X., Zhao, J., Qiu, Y., Wang, J., Sun, G., Wang, Y., Zhou, L., Wang, S., & Miao, L. (2026) · Journal of Material Science and Technology · doi:10.1016/j.jmst.2026.05.016
Kang, Y., Qian, J., Li, S., Lv, Y., Wang, X., Jin, X., Zhou, M., Li, D., Lv, J., Zheng, H., et al. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2668270
Role of Macrophage Efferocytosis in Cardiovascular Homeostasis and Disease
Lin, H., Zhu, X., Sun, Y., Yang, Y., Fan, A., Yang, K., Gao, Z., Ma, C., Fan, G., & Li, L. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl49006
Effects of Myrcia splendens extract on innate inflammatory response
Pitz, M. A. C., Benvenutti, L., Paganelli, C. J., Reichert, T., Quintão, N. L. M., Alberton, M. D., Santin, J. R., & Machado, I. D. (2026) · Rodriguésia · doi:10.1590/2175-7860202677007
Tran, T. U., Hulett, M. D., Nguyen, T. K., & Phan, T. K. (2026) · Methods in cell biology · doi:10.1016/bs.mcb.2026.05.023
Ji, Y., Liu, Y., Wang, Y., Li, H., Lv, C., Wang, X., Wang, H., Song, X., Yan, B., & Chen, L. (2026) · ACS Nano · doi:10.1021/acsnano.6c02211
Qian, Y., Wang, Y., Liu, Y., Geng, Y., Dong, M., Huang, Y., Zhai, C., Wu, Q., Niu, S., Liu, W., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-69062-9
Rewiring cellular immunotherapy: From CAR evolution to circuit innovations across diseases
Chen, J., Cui, Y., Du, K., Liu, J., Xie, J., Wang, S., & Yang, Z. (2026) · Biotechnology Advances · doi:10.1016/j.biotechadv.2026.108980
Neuronal Guidance Proteins in the Fundamental Biology of Inflammation Resolution
Mirakaj, V. (2026) · Current topics in microbiology and immunology · doi:10.1007/82_2026_349
CX3CR1-mediated extracellular Tau internalization and phagosomal proteins in iPSC-derived microglia
Narayanappa, T. S., Ananthanarayana, V., & Chinnathambi, S. (2026) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2026.07.011
The triple-hit hypothesis: exploring pulmonary e-cigarette, PM 2.5 and viral polyexposure
Clemén, H., Ramu, S., & Uller, L. (2026) · European Respiratory Review · doi:10.1183/16000617.0036-2026
Chen, H.-L., Wang, R., Tao, W.-J., Zhang, W., Gao, Y.-L., & Cheng, X.-B. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112265
Li, D., Huang, Y. N., Chen, X.-Q., Lp, Z., Gong, Q., Li, Q., Li, Y., Xu, Y., & Huang, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1886016
Unlocking the potential of macrophages: Advancements in cellular immunotherapy
Chavda, V. P., Vaghela, D. A., Vyas, A., Balar, P. C., Sheth, T. J., & Chokshi, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27731-3.00003-6
Macrophage efferocytosis in pregnancy and pregnancy complications
Brady, C. A., & Belchamber, K. B. R. (2026) · Reproduction and Fertility · doi:10.1530/raf-26-0041
Liu, Z., Wu, J., Lyu, J., Zhou, Z., & Huang, Y. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.07.051
Proximity-regulating nanotechnology for tumor treatment
Yuan, S., Li, Y., Guo, X., & Zhou, S. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115240
Multi-omics Identifies Hub Genes and Immune Networks in Stroke-CAD ComorbidityPreprint
Tian, Y., Xu, Q., Guo, S., Mei, S., Huaqiang, W., Zhao, W., Zhao, Y., Wei, H., Liu, W., Li, L., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9361787/v1
Remodeling macrophage efferocytosis and phenotype via targeted nanoimmunotherapy for atherosclerosis
He, Z., Luo, Y., Li, Y., Yang, S., Fan, Y., Zhang, Y., Liu, S., Zhou, Z., Cao, C., Shi, H., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.08.006
Cytokinesis Arrest-induced Binucleation of Macrophages Produces Highly Efficient EfferocytesPreprint
Wu, X., Wang, Z., Xue, C., Li, F., Yue, J., Shern, T., Liu, W., Cui, J., Wu, C. W., Kissner, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.10.731793
Sahu, K., Satapathy, T., Sahu, P., Chandrakar, O., & Satapathy, A. (2026) · TransMed · doi:10.1016/j.tmed.2026.100041
Tang, S., & Liu, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1938524
Yang, Y., Chen, W., Luo, H., (4899157), Z. Y., Yin, W., Wang, X., Wang, H., Du, B., He, Y., & Yang, P. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103557
Wang, X., Deng, J., Shi, D., 刘志广, Wang, L., & Wu, G. (2026) · Brain and Behavior · doi:10.1002/brb3.71657
Tau-targeting pharmacological strategies in neurodegenerative disease
Zheng, H., & Zheng, J. (2026) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2026.07.008
Efferocytosis related KCTD12 is a clinico-immune target in lung adenocarcinoma
Shan, W., Cao, G., Liu, Y., & Zhu, Y. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1930176
Shen, X., Yu, Q., Shen, Y., Zhang, B., Ye, X., Ying, Y., Wu, Y., Sun, X., Zhang, D., & Liu, Y. (2026) · ACS Nano · doi:10.1021/acsnano.6c06395
Efferocytosis regulatory factors in atherosclerosis: A preclinical systematic review
Zhao, Y., Wu, K., Wang, H., Xu, C., Wei, Q., Li, M., Yang, D., Chen, M., & Zhang, D. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154484
Zhang, Y. (2026) · Theoretical and Natural Science · doi:10.54254/2753-8818/2026.36329
Macrophage lipid efflux regulates the tumour microenvironment in early‐stage lung adenocarcinoma
Zheng, Y., Wang, Y., Wang, Y., Shi, Y., Kong, H., Lu, S., Zhang, Y., Hu, J., Zhou, J., Wang, X., et al. (2026) · Clinical and Translational Discovery · doi:10.1002/ctd2.70199
Duan, X., Ma, P., Ao, X., Li, X., Huang, J., & Song, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1933734
Xiong, H., Li, X., Liu, S., Duan, Q., Wang, Z., Jiang, X., Liu, S., Liu, P., & Cai, K. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.181145
Suzuki, S., Hirata‐Tsuchiya, S., Nagamachi, A., Tsai, S.-H., Kusaka, I., Li, A., Matsuda, S., Mizuno, N., Jimi, E., Inaba, T., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-10869-7
Ou, K., Liang, Y., Li, Y., Tian, L., Chen, J., Wang, J., Zhu, W., Zhuang, L., Wang, Q., & Gong, T. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.08.056
Blum, L., Jäger, K., Jones, M., Elrod, J., Boettcher, M., & Knopf, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1850388
Brahadeeswaran, S., & Tamizhselvi, R. (2026) · Journal of drug targeting · doi:10.1080/1061186x.2026.2729353
Li, S., Li, J., Zhang, Z., Wang, S., & Ma, C. (2026) · Cancer Medicine · doi:10.1002/cam4.72195
Wang, J., Yu, R., Zhou, X., Huang, L., Li, X., Zou, J., Deng, Y., Yang, F., & Yang, Y. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71698
Erythropoietin impacts immune adaptation through myeloid-cell programming
Zhang, X., & Engleman, E. G. (2026) · Trends in Immunology · doi:10.1016/j.it.2026.08.014
Pan, H., Huang, J., Zhu, H., Chen, L., Huang, S., Huang, Y., Zhu, X., Li, X., & Liu, C. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103696
Lin, X., Du, W., Fang, R., Ma, Y., Wang, Y., & Yang, J. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.09.031
Meng, L., Liu, R., Wang, S., Wang, J., Vinnikov, I. A., Yang, R., Song, X., Zhang, H., Wang, J., & Zhang, W. (2026) · iScience · doi:10.1016/j.isci.2026.117739
Liu, Y., Wu, Z., Huang, B., Ye, W., Xu, S., He, W., Lan, Y., Xiao, C., Qin, C., Gao, W., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117439
Nilsson, P., Johansson, E., & Andersson, L. (2025) · Specialty journal of Pharmacognosy Phytochemistry and Biotechnology · doi:10.51847/ry2vdp6lbq
Valtierra‐Alvarado, M. A., Roberts, L. M., Jessop, F., Wehrly, T. D., Thomas, S. M., Schwarz, B. H., Bohrnsen, E., Hablewitz, J., Saturday, G. A., Shaia, C., et al. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag254
Porter, A. B., Smith, K., Hassib, H., Willison, A., Elhassanny, M., Rothlin, C. V., Ghosh, S., Theus, M. H., & Soliman, E. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107618
CD47-mediated efferocytosis in diseases: A comprehensive review
Wang, C., Yu, S., Kang, J., Yang, S., Pan, Z., Zhao, Y., Li, C., & Zhu, W. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12854-z
Ju, M., Zhang, M., Ma, S., An, Y., Xiao, S., Xu, J., Li, N., Chen, Y., Wei, M., Wang, H., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.10.003
Once yearly cell-based therapy for sustained and dose-tunable delivery of monoclonal antibodies
Fell, C., Davis, A. E., Pandey, S., Guinn, M. T., Wang, Z., DeBonis, J., Smith, C., Brown, N., Murungi, D., 김연주, et al. (2026) · Science Advances · doi:10.1126/sciadv.aej5440
Kairyak, O. V. (2026) · Herald of Pancreatic Club
Ubiquitination of LMP-1 by UFD-2 regulates apoptotic cell clearance
Yuan, L., Li, P., Li, X., Xi, Y., Liu, F., Zheng, Q., Wang, H., & Xiao, H. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01886-4
Synergistic Regulation of Biomaterials and Macrophages: A Novel Paradigm in Immunotherapy
张佳宇, Xing, S., Zhang, S., Hao, Y., Qu, X., Bao, W., Hao, M., Sun, H., Dong, M., Zhang, H., et al. (2026) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.70079
Wang, X., Mei, J., Li, R., Zhang, Y., Zhao, G., Hu, Y., Yan, G., Sun, H., & Lv, H. (2026) · Human Reproduction · doi:10.1093/humrep/deag160
Wu, H., Yuan, D., He, R., & Liu, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1999085
Manning, B. S., Zhu, L., Murphy, B., Soliman, M. M. H., Shao, C., Param, N., Miyamoto, T., Shinde, R., Carroll, M., & Carroll, M. P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.12.758552
Efferocytosis Remodels Osteoclast Metabolism and Enhances Antibacterial DefensePreprint
Yu, Q., Zhang, J., Qu, Y., Tang, Y., Zhang, Y., Jia, Y., Dai, Q., Huang, Z., Shen, J., Limjunyawong, N., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.13.759003
From Inflammation to Resolution: Therapeutic Insights into Chronic Disease Management
Poznyak, A. V., Mitkin, N. A., Borodko, D. D., & Orekhov, A. N. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.88s.2
Endes, E. A., & Pelen, N. N. (2026) · Bulletin of Mathematical Biology · doi:10.1007/s11538-026-01751-y
Liu, Y., Bian, L., Wang, H., Cui, D., Wu, Z., & Zhai, B. (2026) · Holistic Integrative Oncology · doi:10.1007/s44178-026-00303-7
Natural products targeting efferocytosis: Bioactivities and therapeutic potential
Zhang, G., Geng, B., Zhang, S., & Xu, J. (2026) · Studies in natural products chemistry · doi:10.1016/b978-0-443-51068-7.00016-7
Novel Mechanometabolic Signaling Cascade Linking Efferocytosis to Inflammation Resolution
kumar, D., Pandit, R., Frausto, L., Governale, T.-A., Yuan, S. S., Fieira, J. N., Quaye, A., McGee, K., Das, S. R., Anand, S. K., et al. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.126.325444
Hu, Z., Wang, H., Huang, J., Zhou, J., Hou, J., Miao, H., Tan, H., Wang, Y., Hu, H., Li, N., et al. (2026) · Advanced Science · doi:10.1002/advs.78367
Zhang, Y., Chen, Y., Cheng, Y., Li, R., Chen, W., Li, Y., Fan, Q., Zhou, Y., Huang, T., Xie, W., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02482-y
Immune Cell Dynamics in Living Tissues: Insights From Intravital Microscopy
Byeon, H., Kim, D., Choi, H., Lee, J., & Lee, J. (2026) · Immune Network · doi:10.4110/in.2026.26.e41
Guo, Y., Wang, Y., & Li, H. (2026) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2026.100648
Sun, J., Wang, T., He, A., Li, J., Guo, J., Xiao, J., Pan, H., 潘光明, Li, F., & Guo, S. (2026) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2026.101827
Xu, J., Wang, Y., Chen, Y., Fang, N., Lu, X., Zhang, H., Wang, K., Liu, X., Zhou, K., Zhang, H., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.183905
Xiao, W., Liu, Y., Xie, Y., Chen, F., Han, X., Yan, S., Cao, Y., & Jiang, Y. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122613
Isot, I. (2025) · Dspace Repository (Marmara Üniversitesi)
Metadata
- Authors
- Mehrotra, P., & Ravichandran, K. S.
- Affiliations
- VIB-UGent Center for Inflammation Research (BE)
- Washington University in St. Louis (US)
- Corresponding author
- Ravichandran, Kodi S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2022-06-01
- Volume
- 21
- Issue
- 8
- Pages
- 601-620
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC9157040
- OpenAlex
- W4281737563
- Cited by
- 459
- References
- 231
- Citations by year
- 2026: 130 · 2025: 153 · 2024: 104 · 2023: 66 · 2022: 6
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL120840)
- National Institute of General Medical Sciences (R35GM122542)
- National Institute of Allergy and Infectious Diseases (R01AI159551)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- efferocytosis, phagocytes, anti-inflammatory mechanism, inflammation resolution, therapeutic target, atherosclerosis, cancer, infection
- MeSH terms
- Homeostasis, Humans, Phagocytes, Phagocytosis, Apoptosis, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
